China Signals Willingness to Negotiate Deal to Keep TikTok in US Day One Biopharmaceuticals Q4 2025 Earnings Progressing Pipeline Despite Wider Loss Osim Founder Ron Sim Drops Legal Claims Against Trek 2000 After New Investor Steps In